These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 373179

  • 1. Specific and nonspecific cytotoxicity of leukocytes from human renal allograft recipients against donor fibroblasts.
    Pierce GE, Barth RF, Vessella RL, Cross DE, Stewart CS.
    Transplantation; 1979 Mar; 27(3):156-62. PubMed ID: 373179
    [Abstract] [Full Text] [Related]

  • 2. Role of humoral presenitization in human renal transplant rejection.
    Gailiunas P, Suthanthiran M, Busch GJ, Carpenter CB, Garovoy MR.
    Kidney Int; 1980 May; 17(5):638-46. PubMed ID: 6995691
    [Abstract] [Full Text] [Related]

  • 3. In situ effector pathways of allograft destruction. 1. Generation of the "cellular" effector response in the graft and the graft recipient.
    Nemlander A, Soots A, Häyry P.
    Cell Immunol; 1984 Dec; 89(2):409-19. PubMed ID: 6391690
    [Abstract] [Full Text] [Related]

  • 4. Donor-specific cellular immunity in rejecting and long-term-surviving class I-disparate rat renal allograft recipients.
    Ruiz P, Fuller J, Sanfilippo F.
    Transplantation; 1990 Jan; 49(1):175-83. PubMed ID: 2301009
    [Abstract] [Full Text] [Related]

  • 5. Study of antibody dependent cellular cytotoxicity (ADCC). II. ADCC activity in renal graft recipients and acute accelerated graft rejection.
    Wasik M, Gradowska L, Lao M, Rowińska D, Orłowski T.
    Arch Immunol Ther Exp (Warsz); 1978 Jan; 26(1-6):311-4. PubMed ID: 373680
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Natural killer cells play a critical role in mediating inflammation and graft failure during antibody-mediated rejection of kidney allografts.
    Kohei N, Tanaka T, Tanabe K, Masumori N, Dvorina N, Valujskikh A, Baldwin WM, Fairchild RL.
    Kidney Int; 2016 Jun; 89(6):1293-306. PubMed ID: 27165816
    [Abstract] [Full Text] [Related]

  • 10. Donor-specific antibodies in renal allograft recipients. A reevaluation of the 51Cr-release assays comparing fibroblast and lymphoid target cells.
    Halloran PF, Aprile M, Haddad G, Cunningham K, Robinette MA.
    Transplantation; 1984 Apr; 37(4):356-8. PubMed ID: 6369664
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Immunologic monitoring of the renal transplant recipient.
    Suthanthiran M, Garovoy MR.
    Urol Clin North Am; 1983 May; 10(2):315-25. PubMed ID: 6222530
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cytomegalovirus-responsive γδ T cells: novel effector cells in antibody-mediated kidney allograft microcirculation lesions.
    Bachelet T, Couzi L, Pitard V, Sicard X, Rigothier C, Lepreux S, Moreau JF, Taupin JL, Merville P, Déchanet-Merville J.
    J Am Soc Nephrol; 2014 Nov; 25(11):2471-82. PubMed ID: 24744438
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The use of tests for cell mediated cytotoxicity in clinical kidney transplantation.
    Dickmeiss E.
    Scand J Urol Nephrol Suppl; 1977 Nov; (42):51-4. PubMed ID: 356222
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.